This breakthrough technology offers advanced solutions for planning and performing spinal fusion procedures, developed in collaboration with DePuy Synthes, a division of Johnson & Johnson. Cential Robotics is proud to announce that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an innovative Spine Navigation Leggi tutto…
The FDA cleared the company’s TriAltis Spine system and the TriAltis navigation-enabled instruments. TriAltis Spine is a next-generation posterior thoracolumbar pedicle screw system. DePuy Synthes’ TriAltis navigation-enabled instruments include drills, taps and screwdrivers. These offer manual operation or power operation for navigated and non-navigated use. The company said combining its Leggi tutto…
Company marks 125 years of innovation WARSAW, Ind., June 23, 2020 – Today, DePuy Synthes*, a Johnson & Johnson Medical Devices Company** announced that more than one million patients globally have been implanted with the ATTUNE® Knee. The milestone coincides with DePuy Synthes’ 125th anniversary this year and highlights the company’s continued dedication Leggi tutto…
New system is designed to enhance anatomic fit and offer surgeons more options to improve patient outcomes. DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, announced the U.S. launch of its Femoral Recon Nail System, a nailing system that provides new options for the surgical treatment of Leggi tutto…